SavedAdd your journal

Journals / The Anatolian Journal of Cardiology / 2019 / Cilt: 21 - Sayı: 2

Turkish Society of Cardiology consensus paper on management of arrhythmia-induced cardiomyopathy

Taner ULUS
KAAN OKYAY
Hasan Kutsi KABUL
Emin Evren ÖZCAN
Özcan ÖZEKE
Hakan ALTAY
Pages
98–106
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It can be resolved by eliminating or effectivelytreating responsible arrhythmia

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Heart failure (HF) is one of the major causes of mortality andmorbidity.
📊
Key Findings & Data:Arrhythmia-induced cardiomyopathy (AIC) is a potentially reversible form of cardiomyopathy(CMP) in which LV dysfunction results from atrial or ventriculararrhythmias (1).
💡
Conclusion & Impact:It can be resolved by eliminating or effectivelytreating responsible arrhythmia
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Heart failure (HF) is one of the major causes of mortality andmorbidity. The identifiation of causes of left ventricular (LV) systolic dysfunction is important in terms of initiating causal treatment and improving prognosis. Arrhythmia-induced cardiomyopathy (AIC) is a potentially reversible form of cardiomyopathy(CMP) in which LV dysfunction results from atrial or ventriculararrhythmias (1). It can be resolved by eliminating or effectivelytreating responsible arrhythmia

🔖

Cite This Article

ULUS, T., OKYAY, K., KABUL, H. K., ÖZCAN, E. E., ÖZEKE, Ö., ALTAY, H. (2019). Turkish Society of Cardiology consensus paper on management of arrhythmia-induced cardiomyopathy. The Anatolian Journal of Cardiology, Cilt: 21 - Sayı: 2, 98–106. https://ajindex.com/articles/365768

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Sossalla S, Vollmann D. Arrhythmia-Induced Cardiomyopathy. Dtsch Arztebl Int 2018; 115: 335-41
  2. Shinbane JS, Wood MA, Jensen DN, Ellenbogen KA, Fitzpatrick AP, Scheinman MM. Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies. J Am Coll Cardiol 1997; 29: 709-15
  3. Gopinathannair R, Sullivan R, Olshansky B. Tachycardia-mediated cardiomyopathy: recognition and management. Curr Heart Fail Rep 2009; 6: 257-64
  4. Gopinathannair R, Etheridge SP, Marchlinski FE, Spinale FG, Lakkireddy D, Olshansky B. Arrhythmia-Induced Cardiomyopathies: Mechanisms, Recognition, and Management. J Am Coll Cardiol 2015; 66: 1714-28
  5. Redfield MM, Jacobsen SJ, Burnett JC Jr, Mahoney DW, Bailey KR, Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003; 289: 194-202
  6. Yokokawa M, Good E, Crawford T, Chugh A, Pelosi F Jr, Latchamsetty R, et al. Recovery from left ventricular dysfunction after ablation of frequent premature ventricular complexes. Heart Rhythm 2013; 10: 172-5
  7. Maisel WH, Stevenson LW. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol 2003; 91: 2D-8D
  8. Santhanakrishnan R, Wang N, Larson MG, Magnani JW, McManus DD, Lubitz SA, et al. Atrial Fibrillation Begets Heart Failure and Vice Versa: Temporal Associations and Differences in Preserved Versus Reduced Ejection Fraction. Circulation 2016; 133: 484-92
  9. Prabhu S, Taylor AJ, Costello BT, Kaye DM, McLellan AJA, Voskoboinik A, et al. Catheter Ablation Versus Medical Rate Control in Atrial Fibrillation and Systolic Dysfunction: The CAMERA-MRI Study. J Am Coll Cardiol 2017; 70: 1949-61
  10. Hsu LF, Jais P, Sanders P, Garrigue S, Hocini M, Sacher F, et al. Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med 2004; 351: 2373-83
  11. Sugumar H, Prabhu S, Voskoboinik A, Kistler PM. Arrhythmia induced cardiomyopathy. J Arrhythm 2018; 34: 376-83
  12. Ellis ER, Josephson ME. What About Tachycardia-induced Cardiomyopathy? Arrhythm Electrophysiol Rev 2013; 2: 82-90
  13. Gupta S, Figueredo VM. Tachycardia mediated cardiomyopathy: Pathophysiology, mechanisms, clinical features and management. Int J Cardiol 2014; 172: 40-6
  14. Spinale FG, Tanaka R, Crawford FA, Zile MR. Changes in myocardial blood flow during development of and recovery from tachycardia induced cardiomyopathy. Circulation 1992; 85: 717-2